These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3218004)

  • 1. [Diagnostic value of determining the levels of lipid-bound sialic acids in the blood in cancer of the kidneys].
    Rubtsov BI; Novikov AM; Figurin KM
    Urol Nefrol (Mosk); 1988; (3):31-3. PubMed ID: 3218004
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
    Polívková J; Vosmiková K; Horák L
    Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
    Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
    Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
    Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
    Dunzendorfer U; Katopodis N; Dnistrian AM; Stock CC; Schwartz MK; Whitmore WF
    Invest Urol; 1981 Nov; 19(3):194-6. PubMed ID: 7298291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of lipid bound sialic acid and acute phase proteins in patients with cancer and nonmalignant disease.
    Raynes JG
    Biomed Pharmacother; 1983; 37(3):136-8. PubMed ID: 6605767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of lipid-bound sialic acid and total sialic acids in the blood].
    Inoue H
    Rinsho Byori; 1983 Mar; Suppl 54():203-7. PubMed ID: 6887579
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the serum levels of seromucoid and sialic acid in women with cervical cancer after brachytherapy].
    Jakielaszek JM; Sobiech KA; Karmowski A; Wieczorek E; Kornafel J
    Wiad Lek; 1986 Aug; 39(15):1035-40. PubMed ID: 3811360
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance of lipid bound sialic acid in sera of cancer patients.
    Shanmugam V; Nagrajan B
    Indian J Cancer; 1986 Sep; 23(3):173-7. PubMed ID: 3623602
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of neopterin determination as a tumour marker in ovarian cancer.
    Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total and lipid-bound sialic acids in the sera of patients with cancer of the stomach and large intestine].
    Oki S
    Nihon Gan Chiryo Gakkai Shi; 1983 Apr; 18(3):692-703. PubMed ID: 6619635
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipid-bound sialic acid: a biological indicator of laryngeal neoplasia].
    Galioto GB; Mevio E; Benazzo M; Galioto P
    Acta Otorhinolaryngol Ital; 1985; 5(5):507-14. PubMed ID: 3843521
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the concentrations of free, lipid-bound and total N-acetylneuraminic acid in rat serum with aging.
    Sugiyama N; Saito K; Tomita K; Miyata T; Nagai Y
    Jpn J Exp Med; 1990 Apr; 60(2):81-3. PubMed ID: 2384979
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood sialic acids in atherosclerosis].
    Gracheva EV; Golovanova NK; Kononova OI; Kozlov SG; Prokazova NV; Liakishev AA
    Biokhimiia; 1995 May; 60(5):718-22. PubMed ID: 7662798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic role of plasma and urinary sialic acid in human carcinoma of uterine cervix.
    Balasubramaniyan N; Subramanian S; Sekar N; Bhuvarahamurthy V; Govindasamy S
    Biochem Mol Biol Int; 1994 Jul; 33(4):617-23. PubMed ID: 7981648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB; Patel PS; Chawda JG; Shah RM
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.